Rivaroxaban
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
This article is a stub. |
Rivaroxaban is a novel oral anticoagulant (NOAC) drug and a Factor Xa inhibitor, which is sold under the brand name Xarelto.[1]
Theory
Evidence
Clinicians
Risks and safety
Costs and availability
See also
Learn more
- Rivaroxaban - drugs.com
- Rivaroxaban - MedlinePlus
- StatPearls
- Xarelto - Drug website
References
- ↑ "Rivaroxaban Uses, Side Effects & Warnings". Drugs.com. Retrieved August 2, 2022.

